Skip to main content

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.

Publication ,  Journal Article
Francis, RO; D'Alessandro, A; Eisenberger, A; Soffing, M; Yeh, R; Coronel, E; Sheikh, A; Rapido, F; La Carpia, F; Reisz, JA; Gehrke, S ...
Published in: J Clin Invest
May 1, 2020

BACKGROUNDGlucose-6-phosphate dehydrogenase (G6PD) deficiency decreases the ability of red blood cells (RBCs) to withstand oxidative stress. Refrigerated storage of RBCs induces oxidative stress. We hypothesized that G6PD-deficient donor RBCs would have inferior storage quality for transfusion as compared with G6PD-normal RBCs.METHODSMale volunteers were screened for G6PD deficiency; 27 control and 10 G6PD-deficient volunteers each donated 1 RBC unit. After 42 days of refrigerated storage, autologous 51-chromium 24-hour posttransfusion RBC recovery (PTR) studies were performed. Metabolomics analyses of these RBC units were also performed.RESULTSThe mean 24-hour PTR for G6PD-deficient subjects was 78.5% ± 8.4% (mean ± SD), which was significantly lower than that for G6PD-normal RBCs (85.3% ± 3.2%; P = 0.0009). None of the G6PD-normal volunteers (0/27) and 3 G6PD-deficient volunteers (3/10) had PTR results below 75%, a key FDA acceptability criterion for stored donor RBCs. As expected, fresh G6PD-deficient RBCs demonstrated defects in the oxidative phase of the pentose phosphate pathway. During refrigerated storage, G6PD-deficient RBCs demonstrated increased glycolysis, impaired glutathione homeostasis, and increased purine oxidation, as compared with G6PD-normal RBCs. In addition, there were significant correlations between PTR and specific metabolites in these pathways.CONCLUSIONBased on current FDA criteria, RBCs from G6PD-deficient donors would not meet the requirements for storage quality. Metabolomics assessment identified markers of PTR and G6PD deficiency (e.g., pyruvate/lactate ratios), along with potential compensatory pathways that could be leveraged to ameliorate the metabolic needs of G6PD-deficient RBCs.TRIAL REGISTRATIONClinicalTrials.gov NCT04081272.FUNDINGThe Harold Amos Medical Faculty Development Program, Robert Wood Johnson Foundation grant 71590, the National Blood Foundation, NIH grant UL1 TR000040, the Webb-Waring Early Career Award 2017 by the Boettcher Foundation, and National Heart, Lung, and Blood Institute grants R01HL14644 and R01HL148151.

Duke Scholars

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

May 1, 2020

Volume

130

Issue

5

Start / End Page

2270 / 2285

Location

United States

Related Subject Headings

  • Male
  • Immunology
  • Humans
  • Glucosephosphate Dehydrogenase Deficiency
  • Female
  • Erythrocytes
  • Erythrocyte Transfusion
  • Blood Preservation
  • Blood Donors
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Francis, R. O., D’Alessandro, A., Eisenberger, A., Soffing, M., Yeh, R., Coronel, E., … Hod, E. A. (2020). Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion. J Clin Invest, 130(5), 2270–2285. https://doi.org/10.1172/JCI133530
Francis, Richard O., Angelo D’Alessandro, Andrew Eisenberger, Mark Soffing, Randy Yeh, Esther Coronel, Arif Sheikh, et al. “Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.J Clin Invest 130, no. 5 (May 1, 2020): 2270–85. https://doi.org/10.1172/JCI133530.
Francis RO, D’Alessandro A, Eisenberger A, Soffing M, Yeh R, Coronel E, et al. Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion. J Clin Invest. 2020 May 1;130(5):2270–85.
Francis, Richard O., et al. “Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.J Clin Invest, vol. 130, no. 5, May 2020, pp. 2270–85. Pubmed, doi:10.1172/JCI133530.
Francis RO, D’Alessandro A, Eisenberger A, Soffing M, Yeh R, Coronel E, Sheikh A, Rapido F, La Carpia F, Reisz JA, Gehrke S, Nemkov T, Thomas T, Schwartz J, Divgi C, Kessler D, Shaz BH, Ginzburg Y, Zimring JC, Spitalnik SL, Hod EA. Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion. J Clin Invest. 2020 May 1;130(5):2270–2285.

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

May 1, 2020

Volume

130

Issue

5

Start / End Page

2270 / 2285

Location

United States

Related Subject Headings

  • Male
  • Immunology
  • Humans
  • Glucosephosphate Dehydrogenase Deficiency
  • Female
  • Erythrocytes
  • Erythrocyte Transfusion
  • Blood Preservation
  • Blood Donors
  • Adult